{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T16:59:36Z","timestamp":1771779576600,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T00:00:00Z","timestamp":1504483200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["CP10.12"],"award-info":[{"award-number":["CP10.12"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["CP15.01"],"award-info":[{"award-number":["CP15.01"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Dutch Government","award":["LSHM15018"],"award-info":[{"award-number":["LSHM15018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00261-017-1285-2","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T01:37:47Z","timestamp":1504489067000},"page":"1215-1222","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["T1 vs. T2 weighted magnetic resonance imaging to assess total kidney volume in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"43","author":[{"name":"On behalf of the DIPAK Consortium","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maatje D. A.","family":"van Gastel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Lianne","family":"Messchendorp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Kappert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merel A.","family":"Kaatee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marissa","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remco J.","family":"Renken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert J.","family":"ter Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shekar V. K.","family":"Mahesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,4]]},"reference":[{"key":"1285_CR1","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","volume":"57","author":"C Patch","year":"2011","unstructured":"Patch C, Charlton J, Roderick PJ, Gulliford MC (2011) Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study. Am J Kidney Dis 57:856\u2013862","journal-title":"Am J Kidney Dis"},{"key":"1285_CR2","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1093\/ndt\/gfs551","volume":"28","author":"HP Neumann","year":"2013","unstructured":"Neumann HP, Jilg C, Bacher J, et al. (2013) Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transplant 28:1472\u20131487","journal-title":"Nephrol Dial Transplant"},{"key":"1285_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y (2007) Autosomal dominant polycystic kidney disease. Lancet 369:1287\u20131301","journal-title":"Lancet"},{"key":"1285_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.2215\/CJN.00330705","volume":"1","author":"J Grantham","year":"2006","unstructured":"Grantham J, Chapman A, Torres V (2006) Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 1:148\u2013157","journal-title":"Clin J Am Soc Nephrol"},{"key":"1285_CR5","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrneph.2009.214","volume":"6","author":"KT Bae","year":"2010","unstructured":"Bae KT, Grantham JJ (2010) Imaging for the prognosis of autosomal dominant polycystic kidney disease. Nat Rev Nephrol 6:96\u2013106","journal-title":"Nat Rev Nephrol"},{"key":"1285_CR6","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2215\/CJN.09500911","volume":"7","author":"AB Chapman","year":"2012","unstructured":"Chapman AB, Bost JE, Torres VE, et al. (2012) Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 7:479\u2013486","journal-title":"Clin J Am Soc Nephrol"},{"key":"1285_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2215\/CJN.03750708","volume":"4","author":"KT Bae","year":"2009","unstructured":"Bae KT, Tao C, Zhu F, et al. (2009) MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancement. Clin J Am Soc Nephrol 4:719\u2013725","journal-title":"Clin J Am Soc Nephrol"},{"key":"1285_CR8","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1007\/s00330-007-0744-5","volume":"17","author":"HS Thomsen","year":"2007","unstructured":"Thomsen HS (2007) European Society of Urogenital Radiology (ESUR). ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis. Eur Radiol 17:2692\u20132696","journal-title":"Eur Radiol"},{"key":"1285_CR9","doi-asserted-by":"publisher","first-page":"461","DOI":"10.2215\/CJN.06011108","volume":"4","author":"MA Perazella","year":"2009","unstructured":"Perazella MA (2009) Current status of gadolinium toxicity in patients with kidney disease. Clin J Am Soc Nephrol 4:461\u2013469","journal-title":"Clin J Am Soc Nephrol"},{"key":"1285_CR10","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.2214\/ajr.169.5.9353444","volume":"169","author":"H Bosmans","year":"1997","unstructured":"Bosmans H, Van Hoe L, Gryspeerdt S, et al. (1997) Single-shot T2-weighted MR imaging of the upper abdomen: preliminary experience with double-echo HASTE technique. AJR Am J Roentgenol 169:1291\u20131293","journal-title":"AJR Am J Roentgenol"},{"key":"1285_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1681\/ASN.2008050507","volume":"20","author":"Y Pei","year":"2009","unstructured":"Pei Y, Obaji J, Dupuis A, et al. (2009) Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 20:205\u2013212","journal-title":"J Am Soc Nephrol"},{"key":"1285_CR12","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1053\/j.ajkd.2013.10.011","volume":"63","author":"E Meijer","year":"2014","unstructured":"Meijer E, Drenth JP, d\u2019Agnolo H, et al. (2014) Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease. Am J Kidney Dis 63:446\u2013455","journal-title":"Am J Kidney Dis"},{"key":"1285_CR13","doi-asserted-by":"publisher","first-page":"e0144526","DOI":"10.1371\/journal.pone.0144526","volume":"10","author":"H Kim","year":"2015","unstructured":"Kim H, Park HC, Ryu H, et al. (2015) Clinical correlates of mass effect in autosomal dominant polycystic kidney disease. PLoS ONE 10:e0144526","journal-title":"PLoS ONE"},{"key":"1285_CR14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1681\/ASN.2013101138","volume":"26","author":"MV Irazabal","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, et al. (2015) Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol 26:160\u2013172","journal-title":"J Am Soc Nephrol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00261-017-1285-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-017-1285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-017-1285-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T17:03:47Z","timestamp":1536685427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00261-017-1285-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,4]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1285"],"URL":"https:\/\/doi.org\/10.1007\/s00261-017-1285-2","relation":{},"ISSN":["2366-004X","2366-0058"],"issn-type":[{"value":"2366-004X","type":"print"},{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,4]]}}}